Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paul Hamilton Chapman, M.D.

Co-Author

This page shows the publications co-authored by Paul Chapman and Helen Shih.
Connection Strength

1.340
  1. Outcome and Toxicity of Proton Therapy for Vestibular Schwannoma: A Cohort Study. Otol Neurotol. 2021 12 01; 42(10):1560-1571.
    View in: PubMed
    Score: 0.243
  2. Adjuvant Radiation Therapy Versus Surveillance After Surgical Resection of Atypical Meningiomas. Int J Radiat Oncol Biol Phys. 2021 01 01; 109(1):252-266.
    View in: PubMed
    Score: 0.222
  3. Proton Stereotactic Radiosurgery for Brain Metastases: A Single-Institution Analysis of 370 Patients. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):820-829.
    View in: PubMed
    Score: 0.189
  4. Spatiotemporal Fractionation Schemes for Irradiating Large Cerebral Arteriovenous Malformations. Int J Radiat Oncol Biol Phys. 2016 Jul 01; 95(3):1067-1074.
    View in: PubMed
    Score: 0.162
  5. Outcomes of proton therapy for patients with functional pituitary adenomas. Int J Radiat Oncol Biol Phys. 2014 Nov 01; 90(3):532-9.
    View in: PubMed
    Score: 0.147
  6. Single-fraction proton beam stereotactic radiosurgery for cerebral arteriovenous malformations. Int J Radiat Oncol Biol Phys. 2014 Jun 01; 89(2):338-46.
    View in: PubMed
    Score: 0.143
  7. Planned two-fraction proton beam stereotactic radiosurgery for high-risk inoperable cerebral arteriovenous malformations. Int J Radiat Oncol Biol Phys. 2012 Jun 01; 83(2):533-41.
    View in: PubMed
    Score: 0.121
  8. Proton stereotactic radiosurgery for the treatment of benign meningiomas. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1428-35.
    View in: PubMed
    Score: 0.112
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.